Cardiovascular Pharmacology and Drug Development

Cardiovascular pharmacology and drug development have seen significant progress, introducing new therapies that enhance treatment options for heart diseases. Recent advancements include PCSK9 inhibitors like alirocumab and evolocumab, which markedly lower LDL cholesterol levels and reduce cardiovascular events. SGLT2 inhibitors, such as empagliflozin and canagliflozin, originally used for diabetes, have demonstrated substantial benefits in heart failure management. ARNi (sacubitril/valsartan) represents a breakthrough in heart failure treatment by combining neprilysin inhibition with angiotensin receptor blockade, improving cardiac function and reducing hospitalizations. Novel anti-fibrotic and anti-inflammatory agents are being explored to target underlying disease mechanisms, potentially slowing or reversing heart damage. Advances in drug delivery systems, including extended-release formulations and targeted therapies, aim to optimize drug efficacy and minimize side effects. These innovations in pharmacology and drug development are enhancing the management of cardiovascular conditions, leading to better patient outcomes and quality of life.

    Related Conference of Cardiovascular Pharmacology and Drug Development

    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    October 17-18, 2024

    38th World Congress on Heart Diseases

    London, UK
    October 17-18, 2024

    3rd International Conference on Cardiology

    London, UK
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    December 12-13, 2024

    5th Global Summit On Heart Congress

    Dubai, UAE
    December 12-13, 2024

    13th World Heart Congress

    Rome, Italy
    December 26-27, 2024

    28th World Cardiology Conference

    Paris, France
    February 20-21, 2025

    35th International Conference on Cardiology and Healthcare

    Amsterdam, Netherlands
    February 20-21, 2025

    14th World Congress on Cardiology

    Amsterdam, Netherlands
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    March 24-25, 2025

    14th World Heart Congress

    Paris, France
    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy

    Cardiovascular Pharmacology and Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in